IP Library Assignment 047582/0020
Patent Assignment
Reel/Frame 047582/0020

Security Interest

Recorded: 2018-11-26 Pages: 11
Assignor
FOCAL THERAPEUTICS, INC.
Executed: 2018-11-14
Assignee
BANK OF AMERICA, N.A., AS COLLATERAL AGENT
100 N TRYON STREET, CHARLOTTE, NORTH CAROLINA, 28255
Covered Properties (18)
Tissue Localization Device and Method of Use Thereof
Device for Accurately Marking Tissue
Patent: 6,564,806 →
Application: 09/507,361 →
Device for Accurately Marking Tissue
Patent: 6,405,733 →
Application: 09/613,686 →
Device for Accurately Marking Tissue
Patent: 6,722,371 →
Application: 09/699,254 →
Device for Accurately Marking Tissue
Patent: 6,752,154 →
Application: 09/935,477 →
Publication: US 2002/0059938
Device for Accurately Marking Tissue
Patent: 7,322,360 →
Application: 10/798,776 →
Publication: US 2004/0168692
Bioabsorbable Target for Diagnostic or Therapeutic Procedure
Patent: 9,014,787 →
Application: 12/790,314 →
Publication: US 2011/0004094
Surgical Implant for Marking Soft Tissue
Application: 13/656,068 →
Publication: US 2013/0289390
Device and Method for Targeted Radiation Therapy
Application: 13/802,041 →
Publication: US 2014/0275984
Diagnostic or Therapeutic Procedure Using Implantable Targets
Patent: 9,199,092 →
Application: 14/581,146 →
Publication: US 2015/0112117
Implantable Devices and Techniques for Oncoplastic Surgery
Patent: 9,615,915 →
Application: 14/808,852 →
Publication: US 2016/0022415
Diagnostic or Therapeutic Procedure Using Implantable Targets
Application: 14/954,589 →
Publication: US 2016/0082286
Implantable Devices and Techniques for Oncoplastic Surgery
Application: 15/456,030 →
Publication: US 2017/0181844
Implantable Devices and Techniques for Oncoplastic Surgery
Patent: 9,980,809 →
Application: 15/456,078 →
Publication: US 2017/0181845
Tissue Localization Device and Method of Use Thereof
Application: 15/488,358 →
Publication: US 2017/0296294
Surgical Implant for Marking Soft Tissue
Application: 15/920,126 →
Publication: US 2018/0200020
Implant for Targeting Therapeutic Procedure
Application: 15/982,903 →
Publication: US 2019/0110858
Bioabsorbable Target for Diagnostic or Therapeutic Procedure
Application: 61/183,010 →
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 13, 2017
From: LEBOVIC, GAIL S.; WILLIS, DAVID B.; HERMANN, GEORGE D.; OLSON, JONATHAN M.
To: FOCAL THERAPEUTICS, INC.
Reel/Frame 041562/0904 →
Assignment of Assignor's Interest Mar 13, 2017
From: LEBOVIC, GAIL S.; WILLIS, DAVID B.; HERMANN, GEORGE D.; OLSON, JONATHAN M.
To: FOCAL THERAPEUTICS, INC.
Reel/Frame 041562/0910 →
Assignment of Assignor's Interest Mar 13, 2018
From: HERMANN, GEORGE D.; WILLIS, DAVID B.; DREWS, MICHAEL J.; LEBOVIC, GAIL S.
To: FOCAL THERAPEUTICS, INC.
Reel/Frame 045582/0604 →
Security Interest Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
Security Interest Oct 15, 2020
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 054089/0804 →
Merger and Change of Name Jul 13, 2021
From: FOCAL THERAPEUTICS, INC.; HOLOGIC, INC.
To: HOLOGIC, INC.
Reel/Frame 056835/0532 →
Security Interest Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →